Your search for cardiovascular disease returned 1004 results

Researchers sought to determine the prevalence of endothelial dysfunction in patients with CVD and history of COVID-19 infection.

Researchers studied the timing and predictors of incident cardiovascular disease in a predominantly Black population with systemic lupus erythematosus.

Physical activity in the morning is associated with lowering the risk for CVD, irrespective of the average total physical activity.

Researchers investigated the associations between artificial sweeteners from all dietary sources and the risk for cardiovascular diseases.

Investigators evaluated long-term cardiovascular outcomes among patients who survived COVID-19 infection.

Weightlifting and moderate-to-vigorous physical activity are associated with a reduced risk for all-cause and cardiovascular mortality.

Individuals with autoimmune disease have an increased risk for developing incident cardiovascular disease.

Researchers compared the QRISK3 and the adjusted Global AntiPhospholipid Syndrome Score in patients with systemic lupus erythematosus to assess their risk of developing cardiovascular disease.

A team of investigators assessed patterns of statin therapy prescribed to patients with atherosclerotic cardiovascular disease with comorbid nondialysis chronic kidney disease.

Increased health-related self-efficacy associated with significantly reduced likelihood of undertreatment

Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.

Researchers studied the relationship between the total burden of arterial plaque and cardiovascular disease risk in patients with systemic lupus erythematosus.

These recommendations only apply to individuals who do not have a history of CVD and are not already taking daily aspirin.

Researchers explored the association between rheumatoid arthritis and cardiovascular disease among US adults aged 20 years and older.

Cereal fiber intake is associated with lower levels of various inflammatory markers and a lower risk of cardiovascular disease.

For individuals with or without hypertension, initiation of sodium-containing acetaminophen is associated with an increased risk for cardiovascular disease.

Researchers at AHA 2021 presented their findings from a study that compared CVD risk factors and in-hospital outcomes in young, Black US adults a decade apart.

Researchers studied the association between urate-lowering therapy and risk for cardiovascular disease in patients with gout, focusing on adherence rates.

Using a population-based cohort, researchers assessed the effects of gout on risk for cardiovascular disease in patients with psoriasis.

Researchers compared the risk factors for unprovoked venous thromboembolism and atherosclerotic cardiovascular disease in patients with rheumatoid arthritis.

Researchers studied the association between maternal hypertensive disorders and risk for cardiovascular outcomes in women with systemic lupus erythematosus.

A comprehensive meta-analysis quantified the risks of several cardiovascular diseases in patients with systemic lupus erythematosus (SLE).

An overview of the increased risk for cardiovascular disease in patients with systemic lupus erythematosus.

Study authors reviewed the evidence on the effectiveness of low-dose aspirin in the primary prevention of cardiovascular disease in systemic autoimmune rheumatic diseases.

Rheumatoid arthritis and systemic lupus erythematosus are associated with increased risk for early-onset atherosclerotic CVD, independent of traditional atherosclerotic risk factors.

A study of patients at a community-based nephrology practice found a higher cardiovascular disease prevalence with hyperuricemia or gout.

The risk for cardiovascular disease is grossly underestimated and may account for the disproportionately high percentage of cardiovascular-related deaths in this population.

Emerging studies aim to better understand therapeutic interventions that may mitigate increased CVD risk in patients with RA.

Researchers assessed the prevalence and incidence rate of cardiovascular morbidity in patients with inflammatory arthritis and determined whether the coexistence of multiple autoimmune disorders was associated with increased risk for cardiovascular disease.

Researchers addressed the association between cardiovascular risk and glucocorticoids in patients with systemic lupus erythematosus.